Edward Pershing - CEO, Director at Provectus Biopharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
CEO, Director
Stock Symbol
PVCT on OTC
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Edward Pershing since 11/22/2023

Holdings reported by Edward Pershing for Provectus Biopharmaceuticals, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Series D-1 Convertible Preferred Stock 1.61M Sep 30, 2024 Direct Common Stock
8% Unsecured Convertible Promissory Note $2.18M Oct 16, 2024 Direct Series D-1 Convertible Preferred Stock

Transactions reported by Edward Pershing for Provectus Biopharmaceuticals, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.